AstraZeneca has completed the acquisition of Alexion Pharmaceuticals, Inc., marking its entry into medicines for rare diseases.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,